[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Boston Scientific Corp (BSX)

Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Boston Scientific (NYSE:BSX) Surprises With Q2 CY2026 Sales But Quarterly Revenue Guidance Misses Expectations

Boston Scientific (NYSE:BSX) Surprises With Q2 CY2026 Sales But Quarterly Revenue Guidance Misses Expectations

BSX : 46.04 (-0.04%)
Boston Scientific: Q2 Earnings Snapshot

Boston Scientific: Q2 Earnings Snapshot

BSX : 46.04 (-0.04%)
Boston Scientific announces results for second quarter 2026

MARLBOROUGH, Mass. , July 29, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.442 billion during the second quarter of 2026, growing 7.5 percent on a reported...

BSX : 46.04 (-0.04%)
Boston Scientific's Restructuring Bet Hinges on Whether Wednesday's Guidance Acknowledges the Trade-Off

Barchart Research What to Expect from BSX Earnings BSX Generated July 28, 2026 Current Price $46.06 EPS Estimate $$0.83 Consensus Rating Strong Buy Average Move 5.27% Boston Scientific's Restructuring...

BSX : 46.04 (-0.04%)
What To Expect From Boston Scientific’s (BSX) Q2 Earnings

What To Expect From Boston Scientific’s (BSX) Q2 Earnings

BSX : 46.04 (-0.04%)
Why Intuitive Surgical’s Strong Quarter Still Spooked Investors

Intuitive Surgical shares fell about 10% after Q2 2026 revenue rose 19% but guidance for da Vinci procedure growth wasn't raised, pushing ISRG below its 200-week moving average.

BSX : 46.04 (-0.04%)
HCA : 408.18 (-2.39%)
MDT : 87.54 (+0.76%)
ISRG : 353.10 (-2.40%)
Boston Scientific (BSX): Buy, Sell, or Hold Post Q1 Earnings?

Boston Scientific (BSX): Buy, Sell, or Hold Post Q1 Earnings?

BSX : 46.04 (-0.04%)
1 Large-Cap Stock with Exciting Potential and 2 We Turn Down

1 Large-Cap Stock with Exciting Potential and 2 We Turn Down

BSX : 46.04 (-0.04%)
CNC : 61.82 (-3.27%)
REGN : 695.42 (+0.03%)
1 Stock Under $50 to Keep an Eye On and 2 We Brush Off

1 Stock Under $50 to Keep an Eye On and 2 We Brush Off

BSX : 46.04 (-0.04%)
ABM : 49.36 (+0.28%)
WD : 50.51 (-0.92%)
Boston Scientific’s Quarterly Earnings Preview: What You Need to Know

Boston Scientific is gearing up for earnings day, weighing a rocky stock run against Wall Street's stubbornly optimistic outlook.

XLV : 166.24 (-0.61%)
BSX : 46.04 (-0.04%)
$SPX : 7,316.15 (-1.52%)

Barchart Exclusives

This Dividend Stock Is Up 22% in a Month Despite Mixed Q2 Earnings. Don’t Sell Just Yet.
Domino’s Pizza stock has rebounded sharply from its 2026 lows. While its valuation multiples have expanded and DPZ does not look as tempting now, dividend investors can stay put in the stock. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.